Revvity

RVTY · Health Care · Market cap $12.6B

Q1 FY26 Apr 5, 2026 reported May 12, 2026

Revenue$0.7B +7% year over year

Gross profit$0.4B

Operating profit$0.1B

Net profit$0B 6% margin

Numbers and detail

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Apr 5, 2026).
Item	Value	Share of revenue	Year over year
Revenue	0.7	100%	+7%
Life Sciences	0.4	57%	+6%
Diagnostics	0.3	43%	+8%
Cost of revenue	−0.3	43%
Gross profit	0.4	55% margin	−2pp
Research & development	−0.1	8%	+0pp
SG&A	−0.2	36%	−2pp
Operating profit	0.1	11% margin	+0pp
Net profit	0	6%	−1pp

All figures in billions of U.S. dollars, for Q4 FY25 (period ends Dec 28, 2025).
Item	Value	Share of revenue	Year over year
Revenue	0.8	100%	+6%
Diagnostics	0.4	50%	+10%
Life Sciences	0.4	50%	+2%
Research & development	−0.1	8%	+1pp
SG&A	−0.3	33%	−1pp
Other	−0.3	45%	+0pp
Operating profit	0.1	14% margin	−2pp
Net profit	0.1	13%	+0pp

All figures in billions of U.S. dollars, for Q3 FY25 (period ends Sep 28, 2025).
Item	Value	Share of revenue	Year over year
Revenue	0.7	100%	+2%
Diagnostics	0.4	57%	+3%
Life Sciences	0.3	43%	+1%
Cost of revenue	−0.3	43%
Gross profit	0.4	54% margin	−3pp
Research & development	−0.1	7%	+0pp
SG&A	−0.2	35%	+0pp
Operating profit	0.1	12% margin	−3pp
Net profit	0	7%	−7pp

All figures in billions of U.S. dollars, for Q2 FY25 (period ends Jun 29, 2025).
Item	Value	Share of revenue	Year over year
Revenue	0.7	100%	+4%
Life Sciences	0.4	57%	+5%
Diagnostics	0.4	57%	+3%
Cost of revenue	−0.3	43%
Gross profit	0.4	55% margin	−1pp
Research & development	−0.1	7%	+0pp
SG&A	−0.2	35%	−2pp
Operating profit	0.1	13% margin	+0pp
Net profit	0.1	7%	−1pp

Quarter by quarter

Pick a quarter and the diagram above changes. Bars compare revenue across the quarters we hold.

Quarter	Period	Reported	Revenue	Year over year	Operating margin	Net profit	Net margin
Q1 FY26	Apr 5, 2026	May 12, 2026	$0.7B	+7%	14%	$0B	6%
Q4 FY25	Sep 29 – Dec 28, 2025	Feb 24, 2026	$0.8B	+6%	12%	$0.1B	13%
Q3 FY25	Jun 30 – Sep 28, 2025	Nov 4, 2025	$0.7B	+2%	14%	$0B	7%
Q2 FY25	Mar 31 – Jun 29, 2025	Aug 5, 2025	$0.7B	+4%	14%	$0.1B	7%